clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT02431533 |
P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
P17 | country | Canada | Q16 |
P582 | end time | 2017-06-01 | |
P4135 | maximum age | 65 | |
P1050 | medical condition | diarrhea | Q40878 |
syndrome | Q179630 | ||
irritable bowel syndrome | Q838966 | ||
P2899 | minimum age | 18 | |
P1132 | number of participants | 94 | |
P4844 | research intervention | calcium oxalate | Q412399 |
P580 | start time | 2016-01-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | The Efficacy of PX0612 In The Treatment Of Irritable Bowel Syndrome: A Randomized, Double-Blind Placebo Controlled Clinical Trial |